Publication:
Importance of collection tube during clinical studies of oseltamivir

Simple item page
dc.contributor.authorNiklas Lindegardhen_US
dc.contributor.authorGeraint R. Daviesen_US
dc.contributor.authorTinh Hien Tranen_US
dc.contributor.authorJeremy Farraren_US
dc.contributor.authorPratap Singhasivanonen_US
dc.contributor.authorNicholas P J Dayen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherUniversity of Liverpoolen_US
dc.contributor.otherUCLen_US
dc.date.accessioned2018-08-24T02:07:04Z
dc.date.available2018-08-24T02:07:04Z
dc.date.issued2007-05-01en_US
dc.description.abstractEx vivo conversion of the anti-influenza drug oseltamivir to its active metabolite can be inhibited by the esterase inhibitor dichlorvos or by using commercial fluoride-oxalate tubes. Oseltamivir and its active metabolite remain intact in plasma samples during a proposed virus heat inactivation step: incubation at 60°C for 45 min. Copyright © 2007, American Society for Microbiology. All Rights Reserved.en_US
dc.identifier.citationAntimicrobial Agents and Chemotherapy. Vol.51, No.5 (2007), 1835-1836en_US
dc.identifier.doi10.1128/AAC.01534-06en_US
dc.identifier.issn00664804en_US
dc.identifier.other2-s2.0-34248381197en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/24916
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34248381197&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleImportance of collection tube during clinical studies of oseltamiviren_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34248381197&origin=inwarden_US

Files

Collections

Scopus 2006-2010